
Biotech News
Amgen Inaugurates Cutting-Edge Facility in Holly Springs
Amgen celebrated the official opening of its state-of-the-art drug substance manufacturing facility in Holly Springs, North Carolina, on January 24. The event, which featured a ribbon-cutting ceremony, marked the first phase of the company’s $1.5 billion investment in the region.